Current concepts in the medical management of metabolic bone disease.
D000328:Adult; D000368:Aged; D001847:Bone Diseases / Q000188:drug therapy*; D002116:Calcitonin / Q000627:therapeutic use; D002648:Child; D002762:Cholecalciferol / Q000627:therapeutic use; D004872:Ergocalciferols / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D008659:Metabolic Diseases / Q000188:drug therapy*; D009520:New Zealand; D063065:Organophosphonates / Q000627:therapeutic use; D010001:Osteitis Deformans / Q000188:drug therapy; D010018:Osteomalacia / Q000453:epidemiology; D010024:Osteoporosis / Q000453:epidemiology; D010281:Parathyroid Hormone / Q000032:analysis; D012507:Sarcoidosis / Q000188:drug therapy; D014807:Vitamin D / Q000506:poisoning; D014808:Vitamin D Deficiency / Q000188:drug therapy
D004872:Ergocalciferols; D063065:Organophosphonates; D010281:Parathyroid Hormone; D014807:Vitamin D; D002762:Cholecalciferol; D002116:Calcitonin